Research Development - Immatics NV (NASDAQ:IMTX) - Alpha Spread

Watchlist Manager

Watchlist

Price: 11.7 USD 19.14%

Updated:

Immatics NV
Research & Development

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Immatics NV
Research & Development Peer Comparison

BNTX

MOR

CVAC

BIO

FYB

Company		Research & Development	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Immatics NV NASDAQ:IMTX	Research & Development -€116.1m	CAGR 3-Years -21%	CAGR 5-Years -29%	CAGR 10-Years N/A
	BioNTech SE NASDAQ:BNTX	Research & Development -€1.8B	CAGR 3-Years -43%	CAGR 5-Years -70%	CAGR 10-Years N/A
	MorphoSys AG XETRA:MOR	Research & Development -€285.7m	CAGR 3-Years -51%	CAGR 5-Years -25%	CAGR 10-Years -19%
	CureVac NV NASDAQ:CVAC	Research & Development -€107.2m	CAGR 3-Years 1%	CAGR 5-Years -21%	CAGR 10-Years N/A
	Biotest AG XETRA:BIO	Research & Development -€81.8m	CAGR 3-Years -25%	CAGR 5-Years -10%	CAGR 10-Years -2%
	Formycon AG XETRA:FYB	Research & Development -€11.5m	CAGR 3-Years -13%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Immatics NV's Research & Development amounts to -116.1m EUR.

Over the last year, the Research & Development growth was -11%. The average annual Research & Development growth rates for Immatics NV have been -21% over the past three years , -29% over the past five years .

Join more than 140,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.